Cellulitis Completed Phase 3 Trials for Linezolid (DB00601)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01339091Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsTreatment
NCT01431339Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsTreatment